Tickers

1. Composite Trajectory Verdict

For a bank holding company, the income statement and balance sheet carry the most weight for assessing financial trajectory, as they directly reflect earnings capacity, margin trends, asset quality, and capital adequacy; the cash flow statement is also important but not available in the provided filings.

Composite Trajectory: Mixed

The income statement shows clear deterioration: net income fell 21% year-over-year to $2.206 billion (10-K 2025-12-31, Table 1), driven by a 5% decline in net interest income to $6.814 billion, a 6% rise in noninterest expense to $6.056 billion, and a 19% increase in provision for credit losses to $514 million. The balance sheet shows growth in loans (+6% to $147.93 billion) and deposits (+4% to $161.58 billion) but significant capital erosion, with the CET1 ratio falling 184 basis points to 11.15% and the total risk-based capital ratio dropping 133 basis points to 13.71% (10-K 2025-12-31, Table 51). Asset quality metrics worsened modestly, with nonaccrual loans rising to 0.88% of total loans from 0.84% and net charge-offs increasing 18.5% to $640 million (10-K 2025-12-31, Tables 34, 35). Liquidity coverage of uninsured deposits declined to 140% from 146% (10-K 2025-12-31, Table 47). The cash flow statement cannot be assessed due to data gaps.

2. Red Flags

• Net income declined 21% YoY to $2.206 billion while noninterest expense rose 6% to $6.056 billion (10-K 2025-12-31, Table 1)
• Net interest margin compressed 29 bps to 3.25% and NIM excluding purchase accounting accretion fell 17 bps to 3.13% (10-K 2025-12-31, Table 1)
• CET1 capital ratio fell 184 bps to 11.15% and Tier 1 risk-based capital ratio fell 162 bps to 11.91% (10-K 2025-12-31, Table 51)
• Net charge-offs increased 18.5% to $640 million, including an $82 million charge-off on a single supply chain finance client (10-K 2025-12-31, Table 34)
• ALLL coverage of nonaccrual loans declined to 119.8% from 141.6% (10-K 2025-12-31, Table 35)
• Uninsured deposit coverage ratio fell to 140% from 146% (10-K 2025-12-31, Table 47)
• Common share repurchases of $3.03 billion occurred alongside $900 million of preferred stock issuance in 2025-2026 (10-K 2025-12-31, Executive Overview)

3. Earnings Assessment (Income Statement)

Earnings Trajectory: Deteriorating

Overall Assessment: Net income fell 21% to $2.206 billion in 2025 from $2.777 billion in 2024 (10-K 2025-12-31, Table 1). Net interest income declined 5% to $6.814 billion as loan yields dropped 59 bps to 6.41% and purchase accounting accretion fell $230 million to $251 million (10-K 2025-12-31, Tables 1, 4). Noninterest income rose 4% to $2.727 billion, driven by rental income (+$48M), wealth management (+$18M), and international fees (+$17M) (10-K 2025-12-31, Table 9). Noninterest expense increased 6% to $6.056 billion, led by personnel costs (+$216M), marketing (+$66M), and equipment (+$51M) (10-K 2025-12-31, Table 10). Provision for credit losses rose 19% to $514 million, with net charge-offs up $100 million to $640 million (10-K 2025-12-31, Tables 8, 34). Return on average assets declined to 0.96% from 1.26% (10-K 2025-12-31, Table 1).

4. Cash Generation Assessment (Statement of Cash Flows)

Cash Trajectory: Insufficient Data

Overall Assessment: The consolidated statements of cash flows are not included in the provided filing excerpts for any period. The 10-K text references cash flow items only indirectly (e.g., debt prepayments, share repurchases, preferred issuance) but does not present operating, investing, or financing cash flow totals. The XBRL data provided covers only balance sheet and income statement line items. Without the cash flow statement, trends in operating cash flow, free cash flow, and cash deployment cannot be evaluated.

5. Balance Sheet Assessment

Balance Sheet Trajectory: Mixed

Overall Assessment: Total assets grew 2.7% to $229.70 billion (10-K 2025-12-31, Consolidated Balance Sheets). Loans and leases increased 6% to $147.93 billion, driven by Commercial Bank growth of $7.64 billion in Global Fund Banking, TMT, and Healthcare (10-K 2025-12-31, Table 24). Deposits rose 4% to $161.58 billion, with noninterest-bearing deposits up 5% to $40.65 billion (25.2% of total) (10-K 2025-12-31, Table 26). Borrowings declined 3% to $36.01 billion following $2.84 billion of debt redemptions (including $2.49 billion Purchase Money Note prepayment) partially offset by $1.85 billion of new issuances (10-K 2025-12-31, Tables 28, 29). However, regulatory capital ratios deteriorated materially: CET1 fell to 11.15% from 12.99%, Tier 1 to 11.91% from 13.53%, and total risk-based capital to 13.71% from 15.04% (10-K 2025-12-31, Table 51). Asset quality showed modest weakening: nonaccrual loans rose to 0.88% of loans from 0.84%, the ALLL-to-loans ratio fell to 1.06% from 1.20%, and ALLL coverage of nonaccrual loans dropped to 119.8% from 141.6% (10-K 2025-12-31, Tables 33, 35). High-quality liquid assets declined to $56.01 billion from $59.34 billion, reducing uninsured deposit coverage to 140% from 146% (10-K 2025-12-31, Table 47).

6. Data Gaps

• Consolidated statements of cash flows for all periods (10-K and 10-Qs)
• Quarterly income statement and balance sheet trends from 10-Q filings (2026-06-30, 2026-03-31, 2025-09-30, 2025-06-30) — only annual 10-K data is fully presented
• Detailed breakdown of cash flow from operations, investing, and financing activities
• Quarterly net interest margin, provision, and expense trends to assess intra-year trajectory
• Quarterly capital ratio and liquidity metrics